Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.

Patel, Ami; Fischer, Cheryl; Lin, Yi-Chih; Basu, Ellen M; Kushner, Brian H; De Braganca, Kevin; Khakoo, Yasmin

Patel, Ami; Fischer, Cheryl; Lin, Yi-Chih; Basu, Ellen M; Kushner, Brian H; De Braganca, Kevin; Khakoo, Yasmin.

Affiliation

Patel A; New York University School of Medicine, New York, New York.
Fischer C; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Lin YC; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Basu EM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Kushner BH; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
De Braganca K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
Khakoo Y; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.

Pediatr Blood Cancer ; 67(8): e28319, 2020 08.

Article in En | MEDLINE | ID: mdl-32543116

Subject(s)
Key words

neuroblastoma; opsoclonus-myoclonus syndrome; revaccination

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Opsoclonus-Myoclonus Syndrome / Neuroblastoma Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2020 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google